Chui-Yee Fong
Overview
Explore the profile of Chui-Yee Fong including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
41
Citations
1259
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kukumberg M, Phermthai T, Wichitwiengrat S, Wang X, Arjunan S, Chong S, et al.
Sci Rep
. 2021 Jan;
11(1):163.
PMID: 33420256
Secretome derived from human amniotic fluid stem cells (AFSC-S) is rich in soluble bioactive factors (SBF) and offers untapped therapeutic potential for regenerative medicine while avoiding putative cell-related complications. Characterization...
2.
Lin H, Fong C, Biswas A, Bongso A
Stem Cell Res Ther
. 2020 Dec;
11(1):527.
PMID: 33298170
Background: The transplantation of human umbilical cord blood (UCB) CD34+ cells has been successfully used to treat hematological disorders but one major limitation has been the low cell numbers available....
3.
Kong C, Arjunan S, Gan S, Biswas A, Bongso A, Fong C
Stem Cell Res
. 2020 Jul;
47:101880.
PMID: 32622342
Gestational diabetes mellitus (GDM) has been strongly associated with an increased risk of type 2 diabetes mellitus (T2DM) in later child and adulthood. The human umbilical cord and its contents...
4.
Lin H, Fong C, Biswas A, Bongso A
Stem Cells Int
. 2020 May;
2020:4670948.
PMID: 32377203
Mesenchymal stem cells from Wharton's jelly of the human umbilical cord (hWJSCs), and the conditioned medium (hWJSC-CM) prepared from them, were shown to be tumoricidal on many cancers. However, these...
5.
Kong C, Lin H, Biswas A, Bongso A, Fong C
Cytotherapy
. 2019 Mar;
21(4):483-495.
PMID: 30879965
Background: Human Wharton's jelly-derived mesenchymal stromal cells (hWJSCs) have gained considerable attention for their use in cell therapy. Many of these applications would require manufacturing of millions of hWJSCs. It...
6.
Raj V, Claudine S, Subramanian A, Tam K, Biswas A, Bongso A, et al.
J Cell Biochem
. 2019 Feb;
120(7):11222-11240.
PMID: 30706534
We showed in previous studies that human umbilical cord Wharton's jelly stem cells (hWJSCs) improved the healing rates of excisional and diabetic wounds in the mouse model. As an extension...
7.
Kong C, Subramanian A, Biswas A, Stunkel W, Chong Y, Bongso A, et al.
Stem Cell Rev Rep
. 2019 Jan;
15(3):415-426.
PMID: 30645713
Gestational diabetes mellitus (GDM) has been associated with an increased risk of maternal and neonatal morbidity. The Wharton's jelly (WJ) of the umbilical cord (UC) is a useful indicator of...
8.
Barrett A, Fong C, Subramanian A, Liu W, Feng Y, Choolani M, et al.
Stem Cells Dev
. 2018 Nov;
28(3):196-211.
PMID: 30484393
Human Wharton's jelly stem cells (hWJSCs) isolated from the human umbilical cord are a unique population of mesenchymal stem cells (MSCs) with significant clinical utility. Their broad differentiation potential, high...
9.
Huang Z, Fong C, Gauthaman K, Sukumar P, Mahyuddin A, Barrett A, et al.
Prenat Diagn
. 2018 Jun;
38(9):673-684.
PMID: 29876942
Objective: Human primitive erythroblasts produced during early embryogenesis have been found in maternal circulation at early gestation and are considered good target cells for noninvasive prenatal diagnosis. We aimed to...
10.
Lin D, Biswas A, Choolani M, Fong C, Bongso A
Stem Cell Rev Rep
. 2017 Sep;
13(6):801-816.
PMID: 28918474
Strategies that induce immunogenic cell death (ICD) or downregulate CD47 or PD-L1 expression have resulted in successful therapeutic options for tumor eradication. Several groups have reported the tumoricidal effects of...